The role of microsatellites as a prognostic factor in primary malignant melanoma

Archives of Dermatology

Volumn 141, Issue 6, 2005, Pages 739-742

  Shaikh, Ladan ^a   Sagebiel, Richard W ^a   Ferreira, Carlos M M ^a   Nosrati, Mehdi ^a   Miller III, James R ^a   Kashani Sabet, Mohammed ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD VESSEL; CANCER RELAPSE; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MELANOMA; METASTASIS; MICROSATELLITE MARKER; MITOSIS; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; THICKNESS; TUMOR VOLUME; ULCER; ANALYSIS OF VARIANCE; CANCER INVASION; CANCER STAGING; COMPARATIVE STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MORTALITY; NEEDLE BIOPSY; PATHOLOGY; PREDICTION AND FORECASTING; PROBABILITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SKIN TUMOR; SURVIVAL; TUMOR RECURRENCE;

MICROSATELLITE DNA; TUMOR MARKER;

ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MICROSATELLITE REPEATS; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 21844432408     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.141.6.739     Document Type: Article

References (22)

1. Day CL Jr, Harrist TJ, Gorstein F, et al. Malignant melanoma: prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat. Ann Surg. 1981;194:108-112.
2. Harrist TJ, Rigel DS, Day CL Jr, et al. "Microscopic satellites" are more highly associated with regional lymph node metastases than is primary melanoma thickness. Cancer. 1984;53:2183-2187.
3. Leon P, Daly JM, Synnestved M, Schultz DJ, Elder DE, Clark WH Jr. The prognostic implications of microscopic satellites in patients with clinical stage I melanoma. Arch Surg. 1991;126:1461-1468.
4. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635-3648.
5. Day CL Jr, Mihm MC Jr, Sober AJ, et al. Prognostic factors and melanoma patients with lesions 0.76-1.69 mm in thickness: an appraisal of "thin" level IV lesions. Ann Surg. 1982;195:30-34.
6. Kelly JW, Sagebiel RW, Calderon W, Murillo L, Dakin RL, Blois MS. The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma. Ann Surg. 1984;200:759-763.
7. Kashani-Sabet M, Sagebiel RW, Ferreira CM, Nosrati M, Miller JR III. Vascular involvement in the prognosis of primary cutaneous melanoma. Arch Dermatol. 2001;137:1169-1173.
8. Sagebiel RW. Pathology of melanoma as a basis for prognostic models: the UCSF experience. Pigment Cell Res. 1994;7:101-102.
9. Kashani-Sabet M, Sagebiel RW, Ferreira CM, Nosrati M, Miller JR III. Tumor vascularity in the prognostic assessment of primary cutaneous melanoma. J Clin Oncol. 2002;20:1826-1831.
10. Day CL Jr, Lew RA, Mihm MC Jr, et al. A multivariate analysis of prognostic factors for melanoma patients with lesions ≥3.65 mm in thickness. Ann Surg. 1982;195:44-49.
11. Day CL Jr, Mihm MC Jr, Lew RA. Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51-3.99 mm). Ann Surg. 1982;195:35-43.
12. Rao UN, Ibrahim J, Flaherty LE, Richards J, Kirkwood JM. Implications of microscopic satellites of the primary and extracapsular lymph node spread in patients with high-risk melanoma: Pathologic corollary of Eastern Cooperative Oncology Group Trial E1690. J Clin Oncol. 2002;20:2053-2057.
13. Buzaid AC, Ross MI, Balch CM, et al. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol. 1997;15:1039-1051.
14. Karakousis CP, Temple DF, Moore R, Ambrus JL. Prognostic parameters in recurrent malignant melanoma. Cancer. 1983;52:575-579.
15. Haffner AC, Garbe C, Burg G, Buttner P, Orfanos CE, Rassner G. The prognosis of primary and metastasising melanoma: an evaluation of the TNM classification in 2,495 patients. Br J Cancer. 1992;66:856-861.
16. Cascinelli N, Bufalino R, Marolda R. Regional non-nodal metastases of cutaneous melanoma. Eur J Surg Oncol. 1986;12:175-180.
17. Sutherland CM, Mather FJ, Krementz ET. Factors influencing the survival of patients with regional melanoma of the extremity treated by perfusion. Surg Gynecol Obstet. 1987;164:111-118.
18. Callery C, Cochran AJ, Roe DJ, et al. Factors prognostic for survival of patients with malignant melanoma spread to the regional lymph nodes. Ann Surg. 1982;196:69-75.
19. Kashani-Sabet M, Shaikh L, Miller JR III, et al. NF-κB in the vascular progression of melanoma. J Clin Oncol. 2004;22:617-623.
20. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976-983.
21. Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA. A multifactorial analysis of melanoma, III: prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg. 1981;193:377-388.
22. Mraz-Gernhard S, Sagebiel RW, Kashani-Sabet M, Miller JR III, Leong SP. Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma. Arch Dermatol. 1998;134:983-987.